The AIM2 inflammasome detects double-stranded DNA in the cytosol and induces caspase-1-dependent pyroptosis as well as release of the inflammatory cytokines interleukin 1b (IL-1b) and IL-18. AIM2 is critical for host defense against DNA viruses and bacteria that replicate in the cytosol, such as Francisella tularensis subspecies novicida (F. novicida). The activation of AIM2 by F. novicida requires bacteriolysis, yet whether this process is accidental or is a host-driven immunological mechanism has remained unclear. By screening nearly 500 interferon-stimulated genes (ISGs) through the use of small interfering RNA (siRNA), we identified guanylate-binding proteins GBP2 and GBP5 as key activators of AIM2 during infection with F. novicida. We confirmed their prominent role in vitro and in a mouse model of tularemia. Mechanistically, these two GBPs targeted cytosolic F. novicida and promoted bacteriolysis. Thus, in addition to their role in host defense against vacuolar pathogens, GBPs also facilitate the presentation of ligands by directly attacking cytosolic bacteria. Prominent among the products of these ISGs are several families of interferon-inducible GTPases, such as the 47-kilodalton immunityrelated GTPases and the 65-to 73-kilodalton guanylate-binding proteins (GBPs) 21, 22 . GBPs are conserved among vertebrates, with 11 GBPs in mice and 7 in humans, and exert anti-microbial effects on intracellular bacteria and protozoa 23 . GBP1 and GBP7 restrict Mycobacterium bovis bacillus Calmette-Guérin and L. monocytogenes by recruiting anti-microbial effectors to the pathogen-containing vacuole (PCV) 24 . Several GBPs are recruited onto the Toxoplasma parasitophorous vacuole 25 , and most are also required for restricting the replication of Toxoplasma gondii 23, [26] [27] [28] . In addition, GBPs encoded by genes on mouse chromosome 3 promote recognition of the vacuolar, Gram-negative bacterium Salmonella typhimurium by the innate immune system by destabilizing its PCV, which leads to egress of the bacteria into the cytosol and subsequent detection of its lipopolysaccharide (LPS) by the caspase-11 inflammasome 29 . In this study we found that GBPs encoded by genes on mouse chromosome 3 were a key factor for the activation of AIM2 during infection with F. novicida. In particular, GBP2 and GBP5 controlled the activation of AIM2 by targeting cytosolic F. novicida and inducing lysis of these bacteria by an as-yet-uncharacterized mechanism. We demonstrated that GBP-deficient mice were unable to control infection with F. novicida in vivo. Together our data reveal a function for GBPs during microbial infection, in that GBPs promoted bacteriolysis in the cytosol and the exposure of bacterial DNA to cytosolic sensors of the innate immune system.
The innate immune system detects invading pathogens through membrane-bound and cytosolic pattern-recognition receptors, which recognize microbe-and damage-associated molecular patterns and induce conserved signaling pathways. Nucleic acids and their derivatives are detected by RIG-I-like receptors, cGAS, DAI and RNA polymerases, which results in the induction of type I interferons via the signaling molecule STING and the kinase TBK1 (refs. 1-3) . Cytosolic microbial and host DNA also induces inflammasome formation through AIM2, a member of the PYHIN family of receptors [4] [5] [6] [7] . AIM2 binds double-stranded DNA through its HIN-200 domain 8 and recruits the inflammasome adaptor ASC. ASC rapidly oligomerizes to form a macromolecular inflammasome complex known as an ' ASC speck' , which activates caspase-1. Active caspase-1 promotes the maturation and release of the pro-inflammatory cytokines interleukin 1β (IL-1β) and IL-18. In addition, it induces pyroptosis, a lytic form of cell death that restricts pathogen replication. The AIM2 inflammasome mediates the recognition of DNA viruses as well as that of various Gram-negative and Gram-positive cytosolic bacteria, such as Listeria monocytogenes, Legionella pneumophila, Mycobacterium species and Francisella tularensis subspecies novicida (F. novicida) [8] [9] [10] [11] [12] [13] [14] . Notably, several studies have shown that activation of AIM2 by these bacteria requires bacteriolysis and the subsequent release of bacterial chromosomal DNA into the cytosol 10, 12, 15 .
However, whether the bacteriolysis is accidental or is an active, host-directed mechanism has remained unclear.
The activation of AIM2 via the transfection of synthetic DNA or during infection with a DNA virus is independent of signaling via Toll-like receptors or interferons 9, 13, 16 . In contrast, the activation of AIM2 during infection with F. novicida requires the production of type I interferons, which are induced as a result of the recognition of an as-yet-undefined F. novicida-derived nucleic acid ligand in the cytosol 9, 10, [17] [18] [19] [20] . Consistent with that, the activation of AIM2 inflammasomes in F. novicida-infected cells requires signaling through STING and the transcription factor IRF3 (refs. 9,10,17) . It has been speculated that interferon signaling is necessary to increase cellular AIM2 for the detection of F. novicida DNA 9 , yet interferon-mediated induction of AIM2 is contested, and even small amounts of transfected DNA efficiently trigger activation of AIM2 in an interferon-independent manner 9 . Therefore, it is likely that one or several interferon-inducible factor(s) is (are) required for efficient activation of AIM2 during bacterial infection.
Type I and type II interferons are potent cytokines that exert anti-microbial effects through the induction of a broad transcriptional program involving ~2,000 genes, the so-called 'interferonstimulated genes' (ISGs), many of which remain uncharacterized.
RESULTS

AIM2 activation during F. novicida infection requires interferons
F. novicida is a facultative intracellular Gram-negative bacterium that avoids phagosomal degradation in phagocytes by escaping into the cytosol, a process that requires the Francisella pathogenicity island (FPI). After escaping from the phagosome, F. novicida replicates in the cytosol but also triggers AIM2-dependent activation of caspase-1 (refs. 10,13) . Infection of mouse bone marrow-derived macrophages (BMDMs) with wild-type F. novicida resulted in cell death (pyroptosis; measured by the release of lactate dehydrogenase (LDH)) and the release of IL-1β dependent on AIM2, ASC and caspase-1, while a mutant lacking the FPI (∆FPI) did not activate the inflammasome (Fig. 1a) . STING is linked to the activation of AIM2 during infection with F. novicida 10, 12 . Macrophages deficient in STING (via the 'goldenticket' (Gt) N-ethyl-N-nitrosourea-induced nonfunctional mutation of alleles encoding Tmem173 (called 'Sting Gt/Gt ' here)) had considerable attenuation of their ability to induce expression of type I interferons and activation of the AIM2 inflammasome upon infection with F. novicida 5 (Fig. 1b and Supplementary Fig. 1a ). Consistent with a role for type I interferons in activation of the AIM2 inflammasome 17, 19 , macrophages from mice deficient in Ifnar1, which encodes the receptor for interferon-α (IFN-α) and IFN-β (IFNAR1), or Stat1, which encodes the transcription factor STAT1, displayed significantly less pyroptosis and release of IL-1β when infected with F. novicida than did their wild-type counterparts (Fig. 1c) . To further confirm that activation of AIM2 during infection with F. novicida depended on signaling via type I interferons, we assessed whether exogenous interferons were able to restore inflammasome activation in STINGdeficient BMDMs. As expected, IFN-β restored cell death and the release of cytokines in Sting Gt/Gt BMDMs (Fig. 1d) . The addition of IFN-γ restored cell death and the release of cytokines in both Sting Gt/Gt BMDMs and Ifnar1 −/− BMDMs (Fig. 1d) , which indicated a requirement for a general interferon signature.
The induction of Aim2 mRNA could explain the considerable dependence on type I interferons and signaling via STAT1 during infection with F. novicida 10 . However, activation of the AIM2 inflammasome by transfection of DNA or infection with DNA viruses is independent of interferon signaling 9, 13, 16 . In accordance with those reports, induction of cell death by transfection of the synthetic A r t i c l e s B-form double-stranded DNA poly(dA:dT) at a concentration of 1 µg/ml required AIM2 but was completely independent of STING and STAT1 (Fig. 1e) . The transfection of large amounts of DNA might overload the system and render it independent of interferon signaling. To rule out this possibility, we 'titrated down' the amount of transfected DNA. The activation of AIM2 remained interferon independent even upon the transfection of small quantities of DNA (Fig. 1e) . These results indicated that basal AIM2 was sufficient to initiate inflammasome activation 9, 13 . Indeed, we observed only weak induction of Aim2 mRNA following infection with F. novicida ( Supplementary Fig. 1b) . Finally, we confirmed that F. novicida genomic DNA was as stimulatory as synthetic DNA by transfecting increasing amounts of each into macrophages that had been primed with the synthetic lipopeptide Pam 3 CSK 4 to induce expression of pro-IL-1β. Both types of DNA triggered similar cell death and release of IL-1β (Fig. 1f) , which excluded the possibility that F. novicida DNA had properties that allowed it to evade recognition by AIM2. Together these results indicated that one (or several) IFN-β-or IFN-γ-inducible gene(s) was (were) needed to activate AIM2 specifically during bacterial infection.
Identification of the GBP family by genetic screening To identify ISGs encoding products involved in F. novicida-mediated activation of the AIM2 inflammasome, we screened BMDMs by RNA-mediated interference with small interfering RNA (siRNA). We selected 443 genes with at least twofold higher expression in F. novicida-infected wild-type macrophages than in F. novicidainfected Ifnar1 −/− macrophages 17 and selected 40 additional genes on the basis of published reports 9, 10, 17, 18 (data not shown and Supplementary Table 1) . At 48 h after transfection of siRNA specific for those genes, we infected macrophages with F. novicida and monitored inflammasome activation by measuring the release of IL-1β and incorporation of propidium iodide (as a measure of cell death). Knockdown of most of the 483 genes did not substantially affect the release of IL-1β or cell death (Fig. 2a) . In contrast, knockdown of Gbp2 or Gbp5 resulted in much less F. novicida-mediated release of IL-1β and macrophage death than that of cells treated with nontargeting siRNA, while knockdown of other GBP-encoding genes showed no comparable effect (Fig. 2a) . Gbp2 and Gbp5 had the highest expression among the GBP-encoding genes in macrophages and were substantially and specifically induced upon infection with wild-type F. novicida in a STING-and IFNAR-dependent manner but independently of Toll-like receptor 2 and MyD88 ( Fig. 2b and Supplementary  Fig. 1c-e) . We confirmed by RT-PCR the efficiency of siRNAmediated knockdown of GBP-encoding genes expressed during infection with F. novicida (Supplementary Fig. 2a) . We next confirmed the screening results by knocking down all 11 mouse GBP-encoding genes individually and measuring cell death and IL-1β release (Fig. 2c) . Knockdown of Gbp2 and Gbp5 specifically decreased the F. novicida-mediated release of IL-1β and cell death, as assessed by two different techniques ( Fig. 2c and Supplementary Fig. 2b ).
In conclusion, our screening approach identified GBP2 and GBP5 as two possible ISG products that controlled the activation of AIM2 during infection with F. novicida.
AIM2 activation requires GBP-encoding genes on chromosome 3
To confirm our screening data, we obtained macrophages from wild-type mice, mice deficient in both caspase-1 and caspase-11 (Casp1 −/− Casp4 −/− ; called 'Casp1 −/− Casp11 −/− ' here) or mice that lack the locus on chromosome 3 encoding GBP1, GBP2, GBP3, GBP5 and GBP7 (called 'Gbp chr3 ' here) 23 and infected naive or primed macrophages with F. novicida. Consistent with defective activation of the AIM2 inflammasome, Gbp chr3 -deficient BMDMs displayed a significant reduction in cell death and cytokine release and had a diminished abundance of processed caspase-1 p20 compared with that of their wild-type counterparts, even though their expression of pro-caspase-1, ASC and AIM2 protein was similar to that of wild-type cells (Fig. 3a,b and Supplementary Fig. 3a) . Measuring the incorporation of propidium iodide in real time following infection showed that Gbp chr3 -deficient BMDMs died with delayed kinetics compared with that of wild-type cells and similar to that of Ifnar1 −/− BMDMs (Supplementary Fig. 3b ). To determine if GBPs encoded by genes on npg chromosome 3 were directly involved in the activation of AIM2, we engaged AIM2 by transfecting synthetic DNA into unprimed wildtype and Gbp chr3 -deficient macrophages. Cytosolic DNA triggered LDH release to a similar extent in both groups of cells, even when the amount of transfected DNA was 'titrated down' (Fig. 3c) . Wildtype, Gbp chr3 -deficient and Ifnar1 −/− cells also responded similarly to the transfection of purified F. novicida genomic DNA (Fig. 3d) . Thus, GBPs were not required in the context of DNA transfection, which suggested that they functioned upstream of AIM2-mediated DNA detection.
GBP2 and GBP5 direct parallel pathways of AIM2 activation
Since our screening data suggested that mainly GBP2 and GBP5 were required for the activation of AIM2 (Fig. 2a) , we infected BMDMs from wild-type, Casp1 −/− Casp11 −/− , Gbp chr3 -deficient, Gbp2 −/− or Gbp5 −/− mice with F. novicida and measured activation of the AIM2 inflammasome. Gbp2 −/− BMDMs displayed less death and cytokine release than did wild-type BMDMs (Fig. 4a,b) . Similarly, Gbp5 −/− BMDMs also displayed attenuated inflammasome activation when infected with F. novicida relative to that of their wild-type counterparts ( Fig. 4a,b) . Deficiency in Gbp2 or Gbp5 did not affect cell death in response to DNA transfection, even when we used very small amounts of DNA (Fig. 4c) . To determine if expression of GBP2 or GBP5 could restore activation of the AIM2 inflammasome in Ifnar1 −/− cells, we retrovirally transduced macrophages with constructs expressing GBP2 or GBP5 or with an empty vector (control) and infected them with F. novicida. Such ectopic expression was not able to complement the deficiency in inflammasome activation ( Supplementary Fig. 4a-c) , which suggested that other products of ISGs might be required for the function of GBP2 and GBP5, in line with data showing that GBPs are active and correctly targeted only in the context of the interferon response 25 .
Single deficiency in Gbp2 or Gbp5 did not reduce the activation of AIM2 during infection with F. novicida as much as Gbp chr3 deficiency did (Fig. 4a,b) , which suggested that GBP2 and GBP5 promoted activation of AIM2 through independent pathways. To investigate whether GBP2 and GBP5 acted sequentially or in parallel, we knocked down Gbp2 expression in wild-type, Gbp2 −/− and Gbp5 −/− BMDMs (control 
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Pro-IL-1β Fig. 4d ) and measured inflammasome activation after infection with F. novicida. Knockdown of Gbp2 reduced cell death and release of IL-1β in wild-type BMDMs but not in Gbp2-deficient BMDMs (Fig. 4d) . Treatment with Gbp2-specific siRNA also significantly reduced inflammasome activation in Gbp5 −/− BMDMs (Fig. 4d) , which demonstrated that in Gbp5-deficient cells, GBP2 was still active and was able to promote activation of AIM2. Consistent with that, knockdown of Gbp5 reduced activation of the inflammasome in both wild-type BMDMs and Gbp2 −/− BMDMs (Fig. 4d) . In conclusion, our data suggested that the interferon-inducible GTPases GBP2 and GBP5 controlled non-redundant, parallel pathways that promoted activation of AIM2 during infection with F. novicida.
Escape of F. novicida from phagosomes is GBP independent
Since cytosolic localization of F. novicida is required for the activation of AIM2 and since GBPs promote the destabilization of phagosomes and/or pathogen-containing vacuoles of protozoan parasites or bacteria 23, 27, 29 , we speculated that GBPs might facilitate the escape of F. novicida from phagosomes. We used a phagosome-protection assay 29, 30 based on selective permeabilization of the plasma membrane with digitonin to assay the escape of F. novicida from phagosomes. As reported before 30 , we observed that 90-95% of wild-type F. novicida escaped from phagosomes within a few hours of infection, but this frequency was similar for wild-type BMDMs and Gbp chr3 -deficient BMDMs at various time points after infection (Fig. 5a) . In contrast, ∆FPI F. novicida remained in the phagosome (data not shown). F. novicida is naturally resistant to β-lactam antibiotics and secrete the β-lactamase FTN_1072. Taking advantage of this, we developed an alternative assay to detect cytosolic bacteria based on cleavage of the FRET (Förster resonance energy transfer) reporter probe CCF4 by FTN_1072, which leads to a loss of FRET activity 31, 32 ( Supplementary  Fig. 5 ). We preloaded wild-type, Gbp2 −/− and Gbp chr3 -deficient BMDMs with CCF4-AM, the membrane-permeable form of the reporter, and subsequently infected the cells with wild-type F. novicida, an FTN_1072-deficient strain (the β-lactamase mutant ∆bla) or the ∆FPI mutant. We observed no difference among wild-type, Gbp2 −/− or Gbp chr3 -deficient BMDMs in terms of FRET activity after infection with wild-type F. novicida ( Fig. 5b and Supplementary Fig. 5 ). The ∆FPI and ∆bla mutant strains did not produce any significant FRET signals, similar to the signaling of uninfected macrophages ( Supplementary  Fig. 5 ). Thus, we concluded that GBPs did not control the activation of AIM2 by promoting the escape of F. novicida from phagosomes but that they were active after F. novicida reached the cytosol. This was consistent with our data showing that in unprimed cells, F. novicida-induced expression of GBP-encoding mRNA was dependent on the FPI and on the escape from phagosomes (Fig. 2b) and that cytosolic recognition was required for interferon induction (Supplementary Fig. 1a) .
GBPs promote cytosolic lysis of F. novicida To identify the mechanism by which GBPs controlled the activation of AIM2 during infection with F. novicida, we investigated the subcellular localization of GBPs in infected cells. GBPs are known to co-localize with vacuolar pathogens such as S. typhimurium, M. bovis bacillus Calmette-Guérin and T. gondii, consistent with the ability of GBPs to recruit anti-microbial effector mechanisms to the pathogen and to destabilize PCVs 24, 27, 29 . We observed that both GBP2 and GBP5 were targeted to intracellular F. novicida (Fig. 6a) . Closer examination of GBP-positive F. novicida revealed that GBPs localized to different spots close to or onto the surface of the bacterium (data not shown). However, it was unclear if GBPs targeted the bacterium directly or targeted remnants of the host membrane (i.e., lysed phagosomes) or another closely associated membrane compartment.
Since the irregular shape of GBP-positive bacteria suggested that they were lysed, we next determined if wild-type and Gbp chr3 -deficient cells differed in the abundance of lysed intracellular F. novicida. Viable and lysed intracellular bacteria can be quantified on the basis of propidium iodide staining, since intact bacteria remain protected from the influx of propidium iodide 33 (Fig. 6b) . We tested the assay by quantifying lysed bacteria in wild-type BMDMs infected with wild-type F. novicida or an F. novicida mutant in which the gene encoding the outer membrane protein FopA is deleted (∆fopA) and thus it has lower membrane stability that results in increased intracellular lysis and hyperactivation of the AIM2 inflammasome 15 . We detected significantly larger amounts of propidium iodidepositive ∆fopA F. novicida than wild-type F. novicida (Fig. 6c) , which confirmed the validity of our assay. We next compared the frequency of lysed bacteria in wild-type and Gbp chr3 -deficient macrophages. The Gbp chr3 -deficient BMDMs had a significantly lower frequency of lysed bacteria (positive for staining with antibodies to F. novicida and propidium iodide) (23% on average) than the wild-type BMDMs had (40% on average) (Fig. 6c) .
The macromolecular inflammasome complex known as the ' ASC speck' assembles on genomic DNA released from lysed cytosolic F. novicida 10 . Immunofluorescence analysis revealed mostly irregularly shaped F. novicida in the vicinity of ASC specks (Fig. 6d) . These bacteria released DNA and were often also positive for GBP staining ( Fig. 6d and Supplementary Fig. 6 ). Consistent with that, the number of ASC speck-containing cells was significantly lower in GBP-deficient (Gbp2 −/− , Gbp5 −/− or Gbp chr3 -deficient) BMDMs than in wild-type BMDMs (Fig. 6e) . In conclusion, these findings indicated that GBPs associated with cytosolic F. novicida and, by an as-yet-undefined mechanism, induced lysis of the bacterium, which resulted in DNA release and detection by the cytosolic DNA sensor AIM2, followed by oligomerization of ASC.
GBPs control F. novicida replication
Inflammasome-induced cell death (pyroptosis) restricts intracellular bacteria by removing their replicative niche and reexposing 
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-/- Figure 5 The npg them to extracellular immunological mechanisms 34 . Cell-autonomous immunity, on the other hand, relies on cell-intrinsic mechanisms to restrict bacterial growth without the need for killing the host cell 21 . To determine whether GBPs restricted F. novicida growth through cell-autonomous mechanisms or inflammasome-dependent mechanisms, we infected wild-type, Aim2 −/− , Gbp chr3 -deficient and Ifnar1 −/− BMDMs with wild-type F. novicida expressing green fluorescent protein (GFP) and used flow cytometry to quantify infected cells (more than two bacteria per cell, our specific fluorescence-detection threshold) among the live cell population. We observed a significantly higher percentage of live infected Aim2 −/− , Gbp chr3 -deficient and Ifnar1 −/− BMDMs than live infected wildtype BMDMs (Fig. 7a) . This suggested that deficiency in Ifnar1 or Gbp chr3 , similar to deficiency in Aim2, resulted in a reduction in inflammasome-mediated killing of host cells upon infection. Cell-autonomous growth restriction is an interferon-induced mechanism that is at least partially independent of inflammasomemediated cell death 35, 36 . Therefore, we next determined if Gbp chr3 -deficient BMDMs and Ifnar1-deficient BMDMs also had a defect in restricting intracellular bacterial replication. We infected macrophages with GFP + F. novicida and quantified bacteria (per cell) by both automated microscopy in flow and microscopy at various Fig. 7b and Supplementary Fig. 7a,b) , consistent with a loss of inflammasome-mediated killing of host cells. Bacterial loads were even higher in Gbp chr3 -deficient or Ifnar1-deficient BMDMs, with many cells containing up to 100 bacteria ( Fig. 7b and Supplementary Fig. 7a,b) . The production of reactive oxygen species and nitric oxide is a potent cell-intrinsic anti-microbial mechanism that can also be activated in an interferon-dependent manner. GBP7 has been shown to recruit subunits of the NADPH oxidase to intracellular L. monocytogenes and M. bovis bacillus Calmette-Guérin 24 , and inducible nitric oxide synthase can restrict bacterial growth in a cell-intrinsic manner 21 . However, deficiency in these mechanisms achieved through the use of BMDMs deficient in both inducible nitric oxide synthase and Nox2 did not significantly alter bacteriolysis and inflammasome activation after infection with F. novicida (P = 0.3081, P = 0.2786 and P = 0.0529; Supplementary Fig. 8a,b) . Overall, these data indicated that GBPs encoded by the locus on chromosome 3 participated in growth restriction in two ways: directly, by promoting the lysis of intracellular bacteria by an as-yet-unknown mechanism; and indirectly, by promoting the inflammasome-mediated killing of host cells, thereby removing the intracellular replicative niche of F. novicida.
GBPs control F. novicida replication in vivo
AIM2, ASC and caspase-1 control the replication of F. novicida in vivo in mice 9, 10, 37 . Since GBPs are required for inflammasome activation in vitro, we investigated whether these proteins also have a physiological role in host defense. We infected age-and sex-matched wild-type, Casp1 −/− Casp11 −/− , Gbp2 −/− and Gbp chr3 -deficient mice subcutaneously with 5 × 10 3 colony-forming units of wild-type F. novicida strain U112 and measured the bacterial burden in the liver and spleen at 2 d after infection. As published before 37 , Casp1 −/− Casp11 −/− mice displayed a significantly higher bacterial burden in the liver and spleen than that of wild-type mice (Fig. 8a) . Similarly, Gbp2 −/− and Gbp chr3 -deficient mice showed higher bacterial counts than wildtype mice, similar to or even higher than those of Casp1 −/− Casp11 −/− mice (Fig. 8a) . Consistent with diminished inflammasome activation in vivo, we detected a significantly lower serum concentration of IL-18 in Casp1 −/− Casp11 −/− , Gbp2 −/− and Gbp chr3 -deficient mice than in wild-type mice (Fig. 8b) . To further assess the effects of GBP deficiency in vivo, we analyzed survival. Within 4 d of infection, all Casp1 −/− Casp11 −/− , Gbp2 −/− and Gbp chr3 -deficient mice died, while most wild-type mice survived until the end of the experiment (day 10) (Fig. 8c) . These results confirmed the relevance of our in vitro data and demonstrated that GBPs encoded by the locus on chromosome 3 were important for inflammasome activation and host defense against F. novicida in vivo.
DISCUSSION
Since the activation of AIM2 during infection with the cytosolic pathogen F. novicida required interferon signaling, we investigated the role of the products of ISGs in this process. Our results showed that the interferon-inducible GTPases GBP2 and GBP5 promoted F. novicidamediated activation of the AIM2 inflammasome but were dispensable for the activation of AIM2 upon transfection of DNA. Members of the GBP family take part in interferon-induced cell-autonomous immunity and are known to induce disruption of the PCVs of vacuolar bacteria and parasites 23, 27, 29 . However, the cytosolic localization of F. novicida was similar in wild-type and Gbp chr3 -deficient cells, which indicated that GBPs must have been involved later during infection, after the bacteria had entered the cytosol. This was consistent with results showing that the escape from phagosomes is an interferonindependent process 36 and that cytosolic localization of F. novicida is a prerequisite for interferon induction 17 . Since the activation of AIM2 during infection with F. novicida or L. monocytogenes is known to require cytosolic bacteriolysis 12,15 , we investigated whether GBPs controlled the bacteriolysis and replication of F. novicida in the cytosol. Significantly fewer lysed and more overall F. novicida were present in cells deficient in GBP-encoding genes or Ifnar1 than in wild-type cells, which indicated that GBPs were required for interferon-mediated cellautonomous immunity to the pathogen. Furthermore, our results demonstrated that in addition to their known function in destabilizing PCVs, GBPs can also promote the lysis of cytosolic bacteria. GBPs are also critical for the cytosolic recognition of LPS and for activation of the caspase-11 inflammasome pathway. In this context, they act by promoting the release of vacuolar S. typhimurium into the cytosol or by promoting activation of caspase-11 during infection with L. pneumophila 29, 38 . At present, no model fully explains how GBPs restrict pathogen growth during infection with microbes or protozoa WT Casp1 and at the same time control inflammasome signaling. It is, however, conceivable that the membrane-destabilizing activity of GBPs in combination with their bacteriolytic activity could not only result in the entry of bacteria into the cytosol but also release microbe-associated molecular patterns (for example, LPS and DNA) directly. Such a model might explain their effect on both the caspase-11 pathway 38 and the AIM2 pathway in response to cytosolic bacteria. Thus, bacteriolysis would also release F. novicida LPS into the cytosol. However, since F. novicida LPS is tetra-acylated, it does not trigger caspase-11 activation 39 . Conversely, we would expect GBPs to lyse cytosolic Salmonella or Legionella, which would result in activation of AIM2. But in this case, activation of AIM2 is most probably masked by a high degree of caspase-11-dependent cell death and cytokine release. GBP-mediated bacteriolysis might also be expected to release DNA and amplify the production of type I interferons via STING. Notably, what triggers initial STING signaling and the induction of GBP-encoding genes during infection with F. novicida is still undefined, but two possibilities exist. One is the direct activation of STING via a secreted bacterial cyclic nucleotide, analogous to infection with L. monocytogenes 40 , and another is activation of the DNA sensor cGAS by F. novicida DNA and subsequent production of the cyclic dinucleotide cGAMP 41, 42 . Lysis of F. novicida within the phagosome followed by translocation of its DNA into the cytosol could trigger interferon production 9 . Alternatively, low levels of F. novicida extracellular DNA could reach the cytosol by sticking to the surface of the infecting bacteria, as suggested for infection with M. tuberculosis 43 . Finally, small amounts of spontaneous bacteriolysis might occur in the host-cell cytosol. If DNA indeed triggers initial STING-mediated production of interferons, it remains to be shown why it is insufficient to trigger activation of AIM2. Additional experiments are needed to determine the relative DNA-binding affinities of cGAS and AIM2 and how their signaling hierarchy is controlled.
Our results have revealed an underappreciated, close connection between cell-autonomous immunity and recognition by the innate immune system. The attack of GBPs on PCVs or pathogens liberates microbe-associated molecular patterns and thus ensures subsequent immunological recognition of the pathogen, which explains the role of interferon signaling in the detection of bacterial DNA by AIM2 or LPS from vacuolar bacteria by the caspase-11 pathway 9, 10, 13, 44, 45 . Additional questions remain, such as how GBP targeting is regulated and how GBPs act mechanistically. Ectopic expression of GBP2 or GBP5 did not 'rescue' the inflammasome deficiency of Ifnar1 −/− cells, which suggests that other products of ISGs are necessary for proper targeting and activity of GBPs 24, 25 . Indeed, members of the IRGM family, a subclass of the immunity-related GTPases, can act as guaninedissociation inhibitors and control the targeting of both immunityrelated GTPases and GBPs to pathogen-containing vacuoles, yet the molecular mechanism of this is still unclear [46] [47] [48] [49] . Additional biochemical studies are needed to define the mechanism of GBP targeting and action during bacterial infection and how this promotes the exposure of bacterial ligands to cytosolic recognition pathways.
METhODS
Methods and any associated references are available in the online version of the paper. Immunofluorescence. Macrophages were seeded on glass coverslips and were infected as described above. At the desired time points, cells were washed three times with PBS and were fixed for 15 min at 37 °C with 4% paraformaldehyde. Following fixation, coverslips were washed, and the fixative was quenched for 10 min at room temperature with 0.1 M glycine. Coverslips were stained for 16 h at 4 °C with primary antibodies (identified below), then were washed with PBS and then incubated for 1 h at room temperature with the appropriate Alexa Fluor-conjugated secondary antibodies (identified below) (1:500 dilution; Invitrogen), then were washed with PBS and mounted on glass slides with Vectashield containing DAPI (6-diamidino-2-phenylindole; Vector Labs). Antibodies used were chicken anti-F. novicida (1:1,000 dilution; a gift from D. Monack), rat anti-ASC (1:1,000 dilution; Genentech), rabbit anti-GBP2 (1:100 dilution; 11854-1-AP; Proteintech) and rabbit anti-GBP5 (1:100 dilution; 13220-1-AP; Proteintech). Secondary antibodies used were as folllows (all at a dilution of 1:500 and all from Life Technologies): goat antirat coupled to Alexa Fluor 488 (A11006), Alexa Fluor 568 (A11077) or Alexa Fluor 633 (A21094); goat anti-rabbit coupled to Alexa Fluor 488 (A11008) or Alexa Fluor 568 (A10042); and goat anti-chicken coupled to Alexa Fluor 488 (A11032), Alexa Fluor 568 (A11047) or Alexa Fluor 633 (A21103). Coverslips were imaged on a Zeiss LSM700 or a Leica SP8 at a magnification of ×63 and vacuolar versus cytosolic bacteria, total intracellular bacteria or ASC specks were quantified as described in the figure legends.
Phagosome protection assay. For quantification of cytoplasmic and vacuolar bacteria, macrophages were infected with GFP + F. novicida as described above. At the desired time point, cells were washed with KHM buffer (110 mM potassium acetate, 20 mM HEPES and 2 mM MgCl2, pH 7.3), followed by incubation for 1 min in KHM buffer with 50 µg/ml digitonin (Sigma). Cells were immediately washed three times with KHM buffer and then were stained for 12 min with Texas Red-coupled chicken antibody to F. novicida (identified above) in KHM buffer with 2% BSA. Cells were washed with PBS, then were fixed and analyzed by microscopy. Controls were included in every assay as described 29 .
Intracellular viability measurement. For measurement of the intracellular lysis of F. novicida, we adapted a published propidium iodide-staining method 33 . Infected BMDMs were incubated for 12 min at 37 °C with Alexa Fluor 488-conjugated mouse antibody to F. novicida (identified above) and 2.6 µM propidium iodide (Sigma) in KHM buffer (described above) for labeling of accessible cytosolic bacteria and compromised bacteria, respectively, in permeabilized cells. Cells were fixed and imaged as described above.
CCF4 measurements. Quantification of escape from vacuoles with the β-lactamase-CCF4 assay was performed following manufacturer's instructions (Life Technologies). Macrophages seeded onto non-treated plates were infected for 1 h as described above, washed and then incubated for 1 h at room temperature in CCF4 in the presence of 2.5 mM probenicid (Sigma). Live (propidium iodide-negative) cells were used for quantification of cells containing cytosolic F. novicida, with excitation at 405 nm and detection at 450 nm (cleaved CCF4) or 510 nm (intact CCF4).
Flow cytometry. For assessment of bacterial replication by flow cytometry, macrophages seeded onto untreated plates were infected as described above with GFP-expressing F. novicida strains. At 8 h after infection, cells were lifted with trypsin and were immediately analyzed by flow cytometry on a FACSCanto II cytometer (BD Biosciences). Dead cells were excluded on the basis of staining with propidium iodide.
ImageStream flow cytometry.
Macrophages infected with GFP-expressing bacteria were fixed in 4% PFA and were analyzed on an ImageStream X Mark II (Amnis; EMD-Millipore) with Inspire software, with the extended depthof-field function activated to increase the accuracy of spot counts. Images of single cells were analyzed with Ideas software (Amnis; EMD-Millipore) with the following steps (each step being confirmed by visualization of at least 20 single cells). Doublets and debris were excluded by morphological parameters (aspect ratio and area in the brightfield channel). Defocused images were eliminated by the Gradient RMS function of the brightfield function. For spot counts and definition of the mean fluorescence of single bacterium, the specific GFP fluorescence signal was defined by application of a mask combining an intensity threshold and a spot to cell background ratio (peak) function. Automatic spot counts were performed with the mask described above. Cells containing a single spot (either a single bacterium or a tight cluster of several bacteria) were gated. The area of the specific signal was analyzed in single cells on the gated population. For the exclusion of bacterial clusters and quantification of the fluorescence of single bacterium, the mean fluorescence intensity was calculated on the GFP + signal covering an area of 1 ± 0.5 µm 2 in 1,599 cells.
Bacteria in single cells were quantified by the automatic spot count function or their numbers were calculated based on the fluorescence of single bacterium. The quantification was identical for cells containing fewer than seven bacteria (R 2 > 0.99). For higher intracellular burden, the spot-count function largely underestimated the number of bacteria per cell due to the difficulty to discriminate bacterial cluster. We thus relied on the specific fluorescence of the bacteria within the cells as defined by the mask described above and the calculated fluorescence value of single intracellular bacterium to quantify bacteria per cell. The mask was applied to at least 10,000 images of single cells per sample to extract the specific fluorescence of the intracellular bacteria in single cells.
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